specialty pharmacies, and independent retailers from the company-owned distribution centers and public warehouses. In the United States, the company distributes pharmaceutical products principally through independent wholesale distributors, with some sales directly to pharmacies and patients. In 2015, three wholesale distributors (McKesson Corporation; Cardinal Health, Inc.; and AmerisourceBergen Corporation) accounted for all of the company’s sales in the United States. Certain products are co-marketed or co-promoted with other companies. Research and Development The company spent approximately $4.3 billion on research to discover and develop new products, indications and processes and to improve existing products and processes in 2015. Significant Events In June 2016, AbbVie and Boehringer Ingelheim have announced a global collaboration to develop and commercialize BI 655066, an anti-IL-23 monoclonal biologic antibody in Phase III development for psoriasis. In July 2015, AbbVie and Bristol-Myers Squibb Company announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of AbbVie's investigational biomarker-specific antibody drug conjugate Rova-T in combination with Bristol-Myers Squibb's Opdivo and Opdivo + Yervoy regimen as a treatment for relapsed extensive-stage small cell lung cancer. Regulation The company’s operations are affected by trade regulations in many countries that limit the import of raw materials and finished products and by laws and regulations that seek to prevent corruption and bribery in the marketplace (including the United States Foreign Corrupt Practices Act and the United Kingdom Bribery Act, which provide guidance on corporate interactions with government officials) and require safeguards for the protection of personal data. History AbbVie Inc. was incorporated in Delaware in 2012.
abbvie inc (ABBV:New York)
1 North Waukegan Road
North Chicago, IL 60064
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for ABBV.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact ABBVIE INC, please visit www.abbvie.com. Company data is provided by Capital IQ. Please use this form to report any data issues.